Ludiflash—A Novel Excipient for Patient Friendly Dosage Form
Abstract
Consumers want a pleasant-tasting and fast-acting tablet that can be taken anywhere, anytime without the need of water. They want such a tablet that completely disintegrates within moments, with no bitterness or chalky aftertaste. FDTs fast disintegrating tablets are the dosage form which will disintegrate in mouth within seconds without need of water. This type of property in dosage form can be attained by addition of different varieties of excipients. But the number of fillers/binders/disintegrant which can be used for FDT formulations is limited because these bulk excipients have to fulfill special requirements, such as being soluble in water, pleasant taste, mouth feel, sweetness and rapid dispersibility. With Ludiflash, that is exactly what they get. This is one of the novel excipient for fast dissolving drug delivery which disintegrant rapidly within seconds with soft, creamy consistency. It is specially designed for direct compression on standard high speed tablet machine for hard tablet with very low friability. Ludiflash have good flow ability, less water absorption and no segregation of the active ingredients. As a result, it can be easily processed. Ludiflash decreases costs because it acts as All-in-one system (filler, binder and disintegrant), lower storage costs (one material, not three), lower analysis costs, faster product development, faster process validation. It acts as patient friendly because it disintegrates in the mouth within seconds with creamy and smooth mouth feel, neutral to mildly sweet, pleasant taste, and suitable for pharmaceutical medicine and nutritional supplements.
Keywords: Ludiflash, Fast dissolving tablet, Novel excipient
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
